Human serum lipids affect Staphylococcus aureus sensitivity to phage infection.

Area of Science:

• Bacteriology
• Virology
• Immunology

Background:

• Phage therapy offers an alternative to antibiotics for multidrug-resistant bacteria.
• Human serum components, particularly plasma and serum, can significantly inhibit staphylococcal phage activity.
• Understanding these inhibitory mechanisms is crucial for developing effective in vivo phage therapies.

Purpose of the Study:

• To identify specific human serum components responsible for inhibiting phage activity against Staphylococcus aureus.
• To determine if this serum-mediated inhibition affects multiple strains of Staphylococcus aureus.
• To investigate the impact of serum lipids on phage-bacteria interactions.

Main Methods:

• Phage Sb-1 activity was tested against S. aureus ATCC 43300 using heat-inactivated human, bovine, and foetal calf serum.
• Serum components like albumin, IgG, and lipids were manipulated (depleted or delipidated) to assess their role in phage inhibition.
• Bacterial growth kinetics were monitored for ten S. aureus strains in the presence of human serum and phage Sb-1.

Main Results:

• Adult human serum completely inhibited phage infectivity, primarily through interactions with bacterial cells, not direct phage neutralization.
• Lipids in the serum were identified as the key inhibitory component, while albumin, IgG, and thermolabile factors had minimal impact.
• The inhibitory effect of serum on phage activity was strain-specific; two S. aureus strains remained susceptible to lysis.

Conclusions:

• Serum lipids significantly impact phage infectivity against Staphylococcus aureus in a strain-dependent manner.
• These findings underscore the need for customized phage therapy approaches considering individual patient serum characteristics.
• Further research into lipid-phage-bacteria interactions is warranted to optimize phage therapy protocols.